Showing results (181-190 of 4,500) with videos related to
Sort By:
Pageof 450
ACS Chemical Neuroscience|March 21, 2013
Influence of the physiochemical properties of superparamagnetic iron oxide nanoparticles on amyloid β protein fibrillation in solutionMorteza Mahmoudi, Fiona Quinlan-Pluck, Marco P Monopoli, et al.ACS Chemical Neuroscience|February 20, 2013
Light-triggered modulation of cellular electrical activity by ruthenium diimine nanoswitchesJoyce G Rohan, Y Rose Citron, Alec C Durrell, et al.ACS Chemical Neuroscience|February 21, 2013
Advances in PET imaging of P-glycoprotein function at the blood-brain barrierStina Syvänen, Jonas ErikssonACS Chemical Neuroscience|February 21, 2013
The molecular and cellular basis of cold sensationDavid D McKemyACS Chemical Neuroscience|February 21, 2013
Synthesis and evaluation of methylated arylazepine compounds for PET imaging of 5-HT(2c) receptorsMichael L Granda, Stephen M Carlin, Christian K Moseley, et al.ACS Chemical Neuroscience|February 21, 2013
The structures of the E22Δ mutant-type amyloid-β alloforms and the impact of E22Δ mutation on the structures of the wild-type amyloid-β alloformsOrkid Coskuner, Olivia Wise-Scira, George Perry, et al.ACS Chemical Neuroscience|February 21, 2013
Restoration of glyoxalase enzyme activity precludes cognitive dysfunction in a mouse model of Alzheimer's diseaseSwati S More, Ashish P Vartak, Robert VinceACS Chemical Neuroscience|February 21, 2013
Glycogen synthase kinase-3 inhibitors as potent therapeutic agents for the treatment of Parkinson diseaseJ A Morales-García, C Susín, S Alonso-Gil, et al.ACS Chemical Neuroscience|February 23, 2013
Aβ42-binding peptoids as amyloid aggregation inhibitors and detection ligandsYuan Luo, Sheetal Vali, Suya Sun, et al.ACS Chemical Neuroscience|May 30, 2013
Synthesis, modeling, and pharmacological evaluation of UMB 425, a mixed μ agonist/δ antagonist opioid analgesic with reduced tolerance liabilitiesJason R Healy, Padmavani Bezawada, Jihyun Shim, et al.Pageof 450